259 related articles for article (PubMed ID: 33017892)
1. New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave.
Lin CC; Huang YC; Lee WC; Chuang YC
Int Neurourol J; 2020 Sep; 24(3):211-221. PubMed ID: 33017892
[TBL] [Abstract][Full Text] [Related]
2. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review.
Trama F; Illiano E; Marchesi A; Brancorsini S; Crocetto F; Pandolfo SD; Zucchi A; Costantini E
Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680774
[TBL] [Abstract][Full Text] [Related]
3. Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment.
Jiang YH; Jhang JF; Lee YK; Kuo HC
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203604
[TBL] [Abstract][Full Text] [Related]
4. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
Kuo HC
Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287
[TBL] [Abstract][Full Text] [Related]
6. The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans.
Mormone E; Cisternino A; Capone L; Caradonna E; Sbarbati A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397003
[TBL] [Abstract][Full Text] [Related]
7. Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives.
Dayem AA; Kim K; Lee SB; Kim A; Cho SG
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32178321
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma.
Lee YK; Jiang YH; Jhang JF; Ho HC; Kuo HC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625918
[TBL] [Abstract][Full Text] [Related]
9. New Frontiers of Extracorporeal Shock Wave Medicine in Urology from Bench to Clinical Studies.
Chen PY; Cheng JH; Wu ZS; Chuang YC
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327477
[TBL] [Abstract][Full Text] [Related]
10. Low energy shock wave therapy attenuates mitochondrial dysfunction and improves bladder function in HCl induced cystitis in rats.
Wang HJ; Tyagi P; Lin TK; Huang CC; Lee WC; Chancellor MB; Chuang YC
Biomed J; 2022 Jun; 45(3):482-490. PubMed ID: 34224911
[TBL] [Abstract][Full Text] [Related]
11. Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection.
Jhang JF; Jiang YH; Hsu YH; Ho HC; Birder LA; Lin TY; Kuo HC
Int Neurourol J; 2022 Feb; 26(Suppl 1):S57-67. PubMed ID: 35073671
[TBL] [Abstract][Full Text] [Related]
12. Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome.
Li H; Zhang Z; Peng J; Xin Z; Li M; Yang B; Fang D; Tang Y; Guo Y
Investig Clin Urol; 2019 Sep; 60(5):359-366. PubMed ID: 31501798
[TBL] [Abstract][Full Text] [Related]
13. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
Jhang JF; Wu SY; Lin TY; Kuo HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
[TBL] [Abstract][Full Text] [Related]
14. Improved symptoms and signs of refractory interstitial cystitis in women after intravesical Nanofat plus platelet-rich plasma grafting: A pilot study.
Hung MJ; Tsai CP; Ying TH; Chen GD; Su HL; Tseng CJ
J Chin Med Assoc; 2022 Jun; 85(6):730-735. PubMed ID: 35507021
[TBL] [Abstract][Full Text] [Related]
15. Novel research approaches for interstitial cystitis/bladder pain syndrome: thinking beyond the bladder.
Mullins C; Bavendam T; Kirkali Z; Kusek JW
Transl Androl Urol; 2015 Oct; 4(5):524-33. PubMed ID: 26813921
[TBL] [Abstract][Full Text] [Related]
16. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L
Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play.
Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
Expert Rev Clin Pharmacol; 2018 May; 11(5):495-505. PubMed ID: 29575959
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety review of current pharmacological treatments for interstitial cystitis/ bladder pain syndrome.
Chen PY; Lee WC; Chuang YC
Expert Opin Drug Saf; 2021 Sep; 20(9):1049-1059. PubMed ID: 33944647
[No Abstract] [Full Text] [Related]
19. Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome.
Kim A; Yu HY; Lim J; Ryu CM; Kim YH; Heo J; Han JY; Lee S; Bae YS; Kim JY; Bae DJ; Kim SY; Noh BJ; Hong KS; Han JY; Lee SW; Song M; Chung HM; Kim JK; Shin DM; Choo MS
Sci Rep; 2017 Aug; 7(1):8872. PubMed ID: 28827631
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Efficacy of Intravesical Platelet-Rich Plasma Injections for Interstitial Cystitis/Bladder Pain Syndrome-A Comparative Study of Different Injection Number, Additives and Concentrations.
Jiang YH; Jhang JF; Lin TY; Ho HC; Hsu YH; Kuo HC
Front Pharmacol; 2022; 13():853776. PubMed ID: 35392571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
